Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
The Incomparable Advanced cameras: Which One Will Win? - 2Former defense minister Gallant vacated home over security threat under Shin Bet direction
- 3How federal officials talk about health is shifting in troubling ways – and that change makes me worried for my autistic child
- 4The most effective method to Alter Your Savvy Bed for A definitive Rest Insight
- 5‘Grit’ and relentless perseverance can take a toll on brain health − particularly for people facing social stresses like racism
- The Way to Recuperation: Defeating Dependence
- Improving as a Pioneer: Examples from My Vocation
- Find Your Ideal Tea: Six Particular Assortments
- Islamic State group militants claim capture and execution of a Nigerian brigadier general
- RFK Jr. says fewer flu shots for kids may be 'better.' What experts say.
- December's overlooked meteor shower peaks next week — will the Ursids surprise us?
- The Force of Systems administration: Individual Examples of overcoming adversity
- UK can legally stop shadow fleet tankers, ministers believe
- Eli Lilly to build $6 billion Alabama plant as part of US manufacturing push
